Professor of Medicine and Chief of Rheumatology Emeritus, University of Massachusetts Medical School
Rheumatology
Dr. Robert B. Zurier, MD
|
|
Give Review
Robert Zurier is an expert in the field of Rheumatology. He went to medical school at University of Texas Southwestern Medical School. He received 1 awards: "Elected Member". Robert B. Zurier is also a published physician. He has 101 publication published. The most recent publication is: Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure.
Publications
- Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.
- Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids.
- Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.
- Cannabinoids, endocannabinoids, and related analogs in inflammation.
- CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis.
- Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells.
- Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma.
- Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients.
- Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid.
- Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al.
- Prostaglandins: then and now and next.
- Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes.
- Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid.
- Prospects for cannabinoids as anti-inflammatory agents.
- Liver abnormalities in rheumatic diseases.
- Oral administration of gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-1beta production by human monocytes.
- Effect of Misoprostol on Acute and Chronic Inflammation.
- Regulation of Macrophage-Independent T-Cell Activation by Prostaglandins and Nonsteroidal Anti-Inflammatory Drugs.
- Treatment of rheumatoid arthritis with marine and botanical oils: an 18-month, randomized, and double-blind trial.
- Effects of cholera enterotoxin on adenosine 3'',5''-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase.
- Developmental abnormalities of terminal deoxynucleotidyl transferase positive bone marrow cells and thymocytes in New Zealand mice: effects of prostaglandin E1.
- Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
- Gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, blocks amplification of IL-1 beta production by human monocytes.
- Polyunsaturated fatty acids and rheumatoid arthritis.
- Oxidative metabolism of anandamide.
- Human peripheral blood T lymphocyte proliferation after activation of the T cell receptor: effects of unsaturated fatty acids.
- Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in ...
- Dimethylheptyl-THC-11 oic acid: a nonpsychoactive antiinflammatory agent with a cannabinoid template structure.
- Effects of unsaturated fatty acids on interleukin-1beta production by human monocytes.
- Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation.
- Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3-mediated signal transduction pathway in human T cells.
- Antirheumatic drug therapy during pregnancy.
- gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial.
- Effects of unsaturated fatty acids on expression of early response genes in human T lymphocytes.
- Treatment of rheumatoid arthritis.
- Marine and botanical lipids as immunomodulatory and therapeutic agents in the treatment of rheumatoid arthritis.
- Botanical lipids: effects on inflammation, immune responses, and rheumatoid arthritis.
- Fatty acids, inflammation and immune responses.
- Treatment of rheumatoid arthritis with gammalinolenic acid.
- Treatment of rheumatoid arthritis with blackcurrant seed oil.
- Effects of fatty acids on proliferation and activation of human synovial compartment lymphocytes.
- Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor-1 mRNA in cultured human endothelial cells.
- Suppression of acute inflammation with liposome associated prostaglandin E1.
- Suppression of monosodium urate crystal-induced inflammation by black currant seed oil.
- Differential regulation of human T lymphocyte protein kinase C activity by unsaturated fatty acids.
- SLE and motherhood.
- Prostaglandins. Their potential in clinical medicine.
- Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators.
- Pinocytosis in human synovial cells in vitro. Evidence for enhanced activity in rheumatoid arthritis.
- Treatment of NZB/W ("lupus") mice with 15(S)-15 methyl PGE1.
- E-rosette formation in multiple sclerosis.
- Suppression of chronic inflammation by evening primrose oil.
- Lymphocyte adherence in multiple sclerosis. Role of monocytes and increased sensitivity of MS lymphocytes to prostaglandin E.
- Adherence of human peripheral blood lymphocytes to virus infected cells: role of the cytoskeleton and prostaglandin E.
- Prostaglandins, immune responses, and murine lupus.
- Antinuclear antibodies in multiple sclerosis.
- Prostaglandin E1 treatment of NBZ/W F1 hybrids--induction of in vitro and in vivo cell-mediated immune response to DNA.
- The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
- Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.
- Inhibition of lung fibroblast growth by human lung mononuclear cells.
- Oral administration of prostaglandin E2 to humans: effects on peripheral blood leukocyte function.
- Suppression of acute and chronic inflammation by orally administered prostaglandins.
- Lymphocyte adherence in multiple sclerosis: lack of virus specificity.
- Cyclic nucleotides and the Chediak-Higashi syndrome.
- Prostaglandins and the inflammatory response.
- Modulation of inflammatory reactions by prostaglandins.
- Enrichment of depot fat with odd and even numbered medium chain fatty acids.
- Use of medium-chain triglyceride in management of patients with massive resection of the small intestine.
- Effect of medium chain triglyceride on cholestyramine-induced steatorrhea in man.
- Relationship between net water absorption and hexanoic acid absorption from the intact human jejunum.
- Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles.
- Effect of prostaglandin E 1 on adjuvant arthritis.
- Effect of bee venom on experimental arthritis.
- Anti-immunologic and anti-inflammatory effects of steroid therapy.
- Mechanisms of lysosomal enzyme release from human leucocytes. III. Quantitative morphologic evidence for an effect of cyclic nucleotides and colchicine on degranulation.
- Leukocytes as secretory organs of inflammation.
- Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.
- Cytochalasin B: effect on lysosomal enzyme release from human leukocytes.
- Leukocytic proteases and the immunologic release of lysosomal enzymes.
- Effect of cyclic AMP on release of lysosomal enzymes from phagocytes.
- Suppression of acute and chronic inflammation in adrenalectomized rats by pharmacologic amounts of prostaglandins.
- Prostaglandins, inflammation, and asthma.
- Mechanisms of lysosomal enzyme release from human leukocytes. I. Effect of cyclic nucleotides and colchicine.
- Prostaglandin E 1 (PGE 1 ) suppression of adjuvant arthritis. Histopathology.
- Enhanced phospholipase A2 and C activities of peripheral blood polymorphonuclear leukocytes from patients with rheumatoid arthritis.
- Monocyte inhibition of lung fibroblast growth: relationship to fibroblast prostaglandin production and density-defined monocyte subpopulations.
- Lymphocyte adherence in multiple sclerosis: role of the cytoskeleton and prostaglandin E.
- Synthesis of prostaglandin E by peritoneal macrophages from NZB/W mice.
- Relapse of systemic lupus erythematosus in a patient receiving cyclosporine A.
- Alteration of uptake and distribution of eicosanoid precursor fatty acids by aspirin.
- Separation and quantification of prostaglandins E1 and E2 as their panacyl derivatives using reverse phase high pressure liquid chromatography.
- Cyclic adenosine 3'5' monophosphate stimulates prostaglandin E production by human adherent synovial cells.
- Stimulus-dependent inhibition of superoxide generation by prostaglandins.
- Effect of PGE1 treatment on in vitro thymocyte function of normal and autoimmune mice.
- Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis.
- Uptake of fatty acids and their mobilization from phospholipids in cultured monocyte-macrophages from rheumatoid arthritis patients.
- Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid.
- Suppression of acute inflammation by 15 methyl prostaglandin E1.
- Vasoactive intestinal peptide synergistically stimulates DNA synthesis in mouse 3T3 cells: role of cAMP, Ca2+, and protein kinase C.
- Suppression of human synovial cell proliferation by dihomo-gamma-linolenic acid.
Schools
University of Texas Southwestern Medical Center At Dallas
Doctors Specialties
- Hematology
- Rheumatology
Accepted Insurances
- MultiPlan PPO
- PHCS Network PPO
Awards
- Elected Member
Education
-
Tufts Medical Center -
St Luke's-Roosevelt Hospital Center -
Boston University Medical Center -
University of Texas Southwestern Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Suzanne M. Gilman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick Hook, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cherry Chang, MD |
|
|
Dr. Mary L. Lopresti, DO |
|
|
Dr. Horace Tang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Youmna Lahoud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan E. Donohue, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muthalagu Ramanathan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kay L. Park, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nahida Islam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John T. Hosey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria E. Abruzzo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Athanasius A. Anagnostou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah M. Demarco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ratnesh Chopra, MD |
|
|
Dr. Tony M. Samaha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman M. Bress, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Yood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Doreen B. Brettler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Horner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine S. Upchurch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles A. Birbara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Fischer, MD |